Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

18 Sep 2013 07:00

RNS Number : 2114O
Standard Life Euro Pri Eqty Tst PLC
18 September 2013
 



 

 

 

 Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2013

 

· NAV rose by 1.4% to 247.3p for the quarter ended 30 June 2013

· NAV total return was up 8.1% for the six months starting 1 January 2013

· Realised gains and income during the quarter ended 30 June 2013 were £7.1 million (1.8% of NAV). The unrealised losses on the portfolio on a constant exchange rate basis were £4.8 million (1.2% of NAV); in addition, there were unrealised foreign exchange gains of £4.2 million (1.1% of NAV).

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2013

· Outstanding commitments were £197.4 million at 30 June 2013

· Net cash was £27.7 million at 30 June 2013

 

For the quarter ended 30 June 2013 the Company's net asset value per ordinary share ("NAV") rose by 1.4% to 247.3p (diluted - 244.2p), from 243.9p (diluted - 240.9p) at 31 March 2013. At 30 June 2013 the Company's net assets were £400.0 million (31 March 2013 - £394.5 million).

 

The volume of new transactional activity remained subdued in the European private equity market in the second quarter of 2013, due to the challenging macro-economic and political environment in Europe. However, supported by increased liquidity in the leveraged debt markets the value of new transactions rose markedly, with a notable rise in the number of large and mega buy-outs. A total of €26.5 billion of transactions by enterprise value was reported during the quarter, which was materially higher than the €10.4 billion reported in the first quarter of 2013. The Manager also continued to see exit activity across the Company's portfolio as private equity managers focused on selling, or in some instances re-capitalising, investee companies.

 

The closing value of the Company's portfolio of 41 private equity fund interests was £374.3 million at 30 June 2013 (31 March 2013 - £375.7 million). The total unrealised losses on the portfolio for the quarter ended 30 June 2013 were £0.6 million, of which £4.8 million were unrealised losses on a constant exchange rate basis and £4.2 million were unrealised foreign exchange gains. The £4.8 million of losses in the value of the portfolio on a constant exchange rate basis reflected weaker listed equity markets, partially offset by positive earnings growth at many underlying portfolio companies. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 3.2% and 2.7% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 1.3% relative to sterling over the quarter.

 

During the quarter the Company funded £7.5 million of draw downs (six months ended 31 March 2013 - £21.1 million) and received £15.5 million of distributions (six months ended 31 March 2013 - £28.5 million). The distributions received generated £7.1 million of realised gains and income, which was equivalent to a return of 1.9 times the acquisition cost of the realised investments.

 

On 28 June 2013 the Company made a new primary fund commitment of €30.0 million to CVC Capital Partners VI. The Company has invested in five prior funds of the manager, CVC Capital Partners.

 

The Company had total outstanding commitments of £197.4 million at 30 June 2013 (31 March 2013 - £177.3 million). At 30 June 2013 the Company had a cash balance of £27.7 million (31 March 2013 - £21.5 million).

 

 

2. Activity since 30 June 2013

 

During the period from 30 June 2013 to 17 September 2013 the Company funded £9.4 million of draw downs and received £13.9 million of distributions. The Company made no new primary fund commitments during the period, however, the Company completed the purchase of an original commitment of €10 million to Bridgepoint Europe IV in July 2013. The fund interest was acquired at a 4% discount to the 31 December 2012 valuation of the fund, adjusted for subsequent cashflows. The purchase price for the fund interest was £7.4 million and the Company assumed £1.6 million of outstanding commitments.

 

In addition, the Company completed the sale of its remaining original commitment of €30 million to Charterhouse VIII in August 2013. The fund interest was sold at a 2% discount to the 31 March 2013 valuation of the fund, adjusted for subsequent cashflows. The sale price for the interest was £18.5 million and the Company was released from £3.4 million of outstanding commitments.

 

Accordingly, at 17 September 2013 the Company's total outstanding commitments and cash balance were £181.6 million and £40.5 million respectively.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2013 on or around 28 November 2013.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXDLFFXKFBBBE
Date   Source Headline
8th Oct 20185:07 pmRNSDirector/PDMR Shareholding
2nd Oct 20181:04 pmRNSQuarterly Disclosure
1st Oct 20187:00 amRNSEstimated Net Asset Value at 31 August 2018
1st Oct 20187:00 amRNSQuarterly Trading Statement
7th Sep 20187:00 amRNSDividend Declaration
30th Aug 20182:24 pmRNSDirector/PDMR Shareholding
28th Aug 20187:00 amRNSChange of Auditor
14th Aug 20187:00 amRNSEstimated Net Asset Value at 31 July 2018
8th Aug 20189:14 amRNSDirector/PDMR Shareholding
3rd Aug 20183:33 pmRNSDirector/PDMR Shareholding
17th Jul 201812:17 pmRNSUpdate research from QuotedData
13th Jul 20183:22 pmRNSEdison reviews Standard Life Private Equity Trust
13th Jul 20187:00 amRNSEstimated Net Asset Value at 30 June 2018
11th Jul 20185:32 pmRNSHolding(s) in Company
5th Jul 201811:55 amRNSDirector/PDMR Shareholding
3rd Jul 201812:43 pmRNSQuarterly Disclosure
18th Jun 20187:02 amRNSEstimated Net Asset Value at 31 May 2018
18th Jun 20187:01 amRNSDividend Declaration
18th Jun 20187:00 amRNSHalf-year Report
15th Jun 201811:50 amRNSDirectorate Change
15th May 20187:00 amRNSEstimated Net Asset Value at 30 April 2018
14th May 20183:48 pmRNSDirector/PDMR Shareholding
8th May 201812:06 pmRNSDirector/PDMR Shareholding
8th May 201812:02 pmRNSDirector/PDMR Shareholding
1st May 201812:54 pmRNSDirector/PDMR Shareholding
18th Apr 20183:24 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSEstimated Net Asset Value at 31 March 2018
4th Apr 20182:09 pmRNSQuarterly Disclosure
26th Mar 20187:00 amRNSEstimated Net Asset Value at 28 February 2018
26th Mar 20187:00 amRNSQuarterly Trading Statement
21st Mar 20187:00 amRNSDividend Declaration
16th Mar 20189:46 amRNSHolding(s) in Company
13th Mar 201810:53 amRNSHolding(s) in Company
8th Mar 201811:00 amRNSKepler Trust Intelligence Research
27th Feb 20185:22 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSEstimated Net Asset Value at 31 January 2018
9th Feb 20183:45 pmRNSDirector/PDMR Shareholding
9th Feb 20183:44 pmRNSDirector/PDMR Shareholding
7th Feb 201811:38 amRNSEdison review: Standard Life Private Equity Trust
2nd Feb 201811:29 amRNSDirector/PDMR Shareholding
31st Jan 20183:17 pmRNSDirector/PDMR Shareholding
25th Jan 20182:48 pmRNSResult of AGM
15th Jan 20187:00 amRNSEstimated Net Asset Value at 31 December 2017
3rd Jan 20182:28 pmRNSQuarterly Disclosure
3rd Jan 201810:52 amRNSDirector/PDMR Shareholding
14th Dec 20177:00 amRNSEstimated Net Asset Value at 30 November 2017
13th Dec 20173:41 pmRNSDirector/PDMR Shareholding
13th Dec 201711:26 amRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDividend Declaration
8th Dec 201711:58 amRNSUpdate research from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.